Recent findings indicate that hypercortisolism can be an underlying contributor to difficult-to-control type 2 diabetes (T2D), and it may occur with lower cortisol levels than noted in overt Cushing syndrome. In this program, expert faculty discuss new perspectives on the...

The pathogenesis of type 1 diabetes (T1D) is now recognized to involve a progression of disease that advances through distinct stages prior to the onset of symptoms. With therapy now available to delay the onset of symptomatic T1D—and give the...

This Burst CME features an expert-led video discussion on TL1A pathophysiology, which has led to a promising new class of biologics for moderate-to-severe IBD with potential to transform care by addressing both inflammatory and fibrostenotic complications. Emerging evidence on TL1A...